TY - JOUR
AU - B. N. Lombardi
AU - A. B. Parisi
AU - H. Newton
AU - B. M. Lombardi
A1 - 
AB - BACKGROUND: Substance use disorders (SUD) and mental health disorders (MHD) are major health concerns during the perinatal period (conception to one year postpartum). However, many individuals with perinatal SUD or MHD do not receive adequate treatment, and most treatment facilities do not offer services tailored to this population's unique needs. This study examines the proportion of treatment facilities in the United States (US) providing perinatal services, as well as facility- and state-level factors associated with offering such services. METHODS: Data were drawn from the 2022 National Substance Use and Mental Health Services Survey, an annual cross-sectional survey of all known public and private SUD and MHD treatment facilities in the US. The sample consisted of 6995 facilities providing SUD treatment (SUD-only) and 9134 facilities offering combined SUD and MHD treatment. Descriptive statistics, bivariate analyses, and multilevel logistic regression models examined treatment facility characteristics and the impact of facility- and state-level factors on the likelihood of offering perinatal services. RESULTS: Only 32.7% of SUD-only treatment facilities and 31.1% of combined SUD/MHD treatment facilities offered perinatal programs. More than half of these treatment facilities provided services critical to the perinatal population, including transportation assistance, social service support, trauma-informed therapy, and telehealth. Payment type (i.e., Medicaid acceptance, offer of free or low-cost treatment), for-profit treatment facility ownership, and receipt of state and federal grant funding were associated with a significantly increased likelihood of the treatment facility providing perinatal services. CONCLUSIONS: Findings indicate there is a pressing need for SUD and MHD treatment facilities to expand their services to include care for individuals in the perinatal period, as well as increase the availability of essential services (e.g., integrated primary care) and ancillary services (e.g., childcare). Further research is needed to understand at which timepoint(s) facilities provide treatment (i.e., pregnancy and/or the postpartum period) and which types of essential and ancillary services are most beneficial during the perinatal period.
AD - Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, 725 Martin Luther King Jr. Blvd., CB# 7590, Chapel Hill, NC 27516, United States of America; School of Social Work, University of North Carolina at Chapel Hill, 725 Martin Luther King Jr. Blvd., CB# 7590, Chapel Hill, NC 27516, United States of America. Electronic address: bnlombardi@unc.edu.; Department of Social Work, George Mason University, 4400 University Drive, MSN IF8, Fairfax, VA 22030, United States of America. Electronic address: aparisi2@gmu.edu.; Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, 725 Martin Luther King Jr. Blvd., CB# 7590, Chapel Hill, NC 27516, United States of America; Department of Family Medicine, University of North Carolina at Chapel Hill, 590 Manning Drive, CB# 7595, Chapel Hill, NC 27514, United States of America. Electronic address: hnewton@email.unc.edu.; Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, 725 Martin Luther King Jr. Blvd., CB# 7590, Chapel Hill, NC 27516, United States of America; School of Social Work, University of North Carolina at Chapel Hill, 725 Martin Luther King Jr. Blvd., CB# 7590, Chapel Hill, NC 27516, United States of America; Department of Family Medicine, University of North Carolina at Chapel Hill, 590 Manning Drive, CB# 7595, Chapel Hill, NC 27514, United States of America. Electronic address: blombard@ad.unc.edu.
AN - 40447109
BT - J Subst Use Addict Treat
C5 - Opioids & Substance Use; Healthcare Disparities
DA - May 29
DO - 10.1016/j.josat.2025.209722
DP - NLM
ET - 20250529
JF - J Subst Use Addict Treat
LA - eng
N2 - BACKGROUND: Substance use disorders (SUD) and mental health disorders (MHD) are major health concerns during the perinatal period (conception to one year postpartum). However, many individuals with perinatal SUD or MHD do not receive adequate treatment, and most treatment facilities do not offer services tailored to this population's unique needs. This study examines the proportion of treatment facilities in the United States (US) providing perinatal services, as well as facility- and state-level factors associated with offering such services. METHODS: Data were drawn from the 2022 National Substance Use and Mental Health Services Survey, an annual cross-sectional survey of all known public and private SUD and MHD treatment facilities in the US. The sample consisted of 6995 facilities providing SUD treatment (SUD-only) and 9134 facilities offering combined SUD and MHD treatment. Descriptive statistics, bivariate analyses, and multilevel logistic regression models examined treatment facility characteristics and the impact of facility- and state-level factors on the likelihood of offering perinatal services. RESULTS: Only 32.7% of SUD-only treatment facilities and 31.1% of combined SUD/MHD treatment facilities offered perinatal programs. More than half of these treatment facilities provided services critical to the perinatal population, including transportation assistance, social service support, trauma-informed therapy, and telehealth. Payment type (i.e., Medicaid acceptance, offer of free or low-cost treatment), for-profit treatment facility ownership, and receipt of state and federal grant funding were associated with a significantly increased likelihood of the treatment facility providing perinatal services. CONCLUSIONS: Findings indicate there is a pressing need for SUD and MHD treatment facilities to expand their services to include care for individuals in the perinatal period, as well as increase the availability of essential services (e.g., integrated primary care) and ancillary services (e.g., childcare). Further research is needed to understand at which timepoint(s) facilities provide treatment (i.e., pregnancy and/or the postpartum period) and which types of essential and ancillary services are most beneficial during the perinatal period.
PY - 2025
SN - 2949-8759
SP - 209722
ST - Characteristics of substance use disorder and mental health disorder treatment facilities with perinatal programs
T1 - Characteristics of substance use disorder and mental health disorder treatment facilities with perinatal programs
T2 - J Subst Use Addict Treat
TI - Characteristics of substance use disorder and mental health disorder treatment facilities with perinatal programs
U1 - Opioids & Substance Use; Healthcare Disparities
U3 - 10.1016/j.josat.2025.209722
VL - 176
VO - 2949-8759
Y1 - 2025
ER -